Keywords |
Page Numbers |
Adipokines |
119 |
Age |
112 |
Anesthesia |
239 |
Antioxidant treatment |
133 |
Assisted conception |
147 |
Assisted reproductive techniques |
203 |
Asymptomatic patient |
232 |
Attachment |
192, 215 |
B-hCG resolution |
198 |
BMI |
112 |
Behavior |
215 |
Calcium channel blocker |
165 |
Catheter ablation |
236 |
Cesarean scar pregnancy |
198 |
Cesarean section |
169, 215 |
Checklist |
227 |
Chemotherapy resistance |
153 |
Childbirth |
209 |
Clinical trial |
184 |
ECT |
239 |
Ectopic pregnancy |
198 |
Education |
209 |
Estrogen |
119 |
Fear |
209 |
Fecal incontinence |
125 |
Fertility |
203 |
First-generation |
133 |
Foeniculum vulgare |
203 |
GTN |
153 |
Ghrelin |
119 |
GnRH antagonist |
165 |
Gonadotropin-releasing hormone agonist (GnRH) agonist |
165 |
HPV |
232 |
Hamadan |
221 |
Hygienic habits |
158 |
Hyperglycosylated human chorionic gonadotropin |
142 |
Hysterectomy |
169 |
Hysteroscopy |
198 |
In vitro fertilization |
147 |
Insulin resistance |
184 |
Intermediate risk |
153 |
Intrauterine growth retardation |
221 |
Intrauterine insemination |
165 |
Iran |
165 |
LH surge |
165 |
Lipid profile |
184 |
Maternal-postnatal attachment scale |
192 |
Metronidazole |
174 |
Mice |
133 |
Model of endometriosis |
133 |
Natural menopause |
112 |
Neurodevelopmental care |
192 |
Nimodipine |
165 |
Ovarian failure |
203 |
Ovarian stimulation |
147 |
PCR |
232 |
POSEIDON criteria |
147 |
Pain |
227 |
Pain control |
227 |
Pap smear |
232 |
Peer group |
209 |
Pelvic floor muscle exercise |
125 |
Pelvic organ prolapse |
125 |
Physical activity |
112 |
Physiologic delivery |
215 |
Physiotherapy |
125 |
Phytotherapy |
203 |
Placenta accreta |
142 |
Placenta previa/accrete |
169 |
Polycystic ovary syndrome |
184 |
Poor ovarian response |
147 |
Postmenopausal obesity |
119 |
Prangos ferulacea |
174 |
Prediction |
142 |
Pregnancy |
158, 236, 239, 221 |
Preterm infant |
192 |
Prevalence |
232 |
Psyllium |
184 |
Reliability |
227 |
Rural |
112 |
Satiation |
119 |
Sexual habits |
158 |
Smoking |
112 |
Third trimester |
169, 239 |
Treatment |
174 |
Trichomonas vaginalis |
174 |
Urban |
112 |
Urinary incontinence |
125 |
Urinary tract infection |
158 |
Validity |
227 |
Ventricular tachycardia |
236 |
Vitamin D |
221 |
|
|